Literature DB >> 16995850

Helicobacter pylori as a promoter of accelerated regeneration, pathological differentiation and transformation of normal gastric mucosa into cancerous type.

Zora Vukobrat-Bijedić1, Svjetlana Radović, Azra Husić-Selimović, Srdan Gornjaković.   

Abstract

The aim of the study was to ascertain presence of Helicobacter pylori in gastric carcinoma as a responsible promoter of inflammatory-regenerative changes, which lead to pathological differentiation and transformation of normal epithelial cells into intestinal type and, in progression, cause epithelial dysplasia that develops into early gastric carcinoma. The paper presents prospective study that includes clinical, pathohistological and microbiological aspects of carcinogenesis initiation in gastric mucosa. The subjects are patients treated at Gastroenterohepatology Clinic divided into two groups. One group included 50 patients with gastric carcinoma while the control group included 50 patients with chronic atrophic H. pylori positive gastritis. All the patients were subjected to endoscopy as well as biopsy targeted at antrum, lesser curvature and corpus and at the region 1-2 cm removed from tumor lesion. We used HUT test to verify H. pylori presence in biopsy samples. We analyzed the samples for presence, frequency and severity of inflammatory-regenerative, metaplastic and dysplastic changes in gastric mucosa and evaluated their meaning for the prognosis. Our study confirmed Helicobaster pylori responsibility for inflammatory events in gastric mucosa in patients with gastric carcinoma. Slight and mild epithelial dysplasia with chronic atrophic gastritis grade I and II coupled with intestinal metaplasia may be considered an indicator for early detection of carcinoma. Such patients represent risk group for gastric carcinoma development.

Entities:  

Mesh:

Year:  2006        PMID: 16995850      PMCID: PMC7193666          DOI: 10.17305/bjbms.2006.3146

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  14 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Helicobacter pylori and gastric cancer: state of the art.

Authors:  P Correa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-06       Impact factor: 4.254

Review 3.  Review article: the role of inflammation in the pathogenesis of gastric cancer.

Authors:  P Ernst
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

4.  Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients.

Authors:  A G Meining; E Bayerdörffer; M Stolte
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

Review 5.  Helicobacter pylori and gastric carcinogenesis.

Authors:  E J Kuipers; S G Meuwissen
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 6.  Premalignant lesions of the stomach.

Authors:  S B Ho
Journal:  Semin Gastrointest Dis       Date:  1996-04

7.  Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy.

Authors:  A V Safatle-Ribeiro; U Ribeiro; M R Clarke; P Sakai; S Ishioka; A B Garrido; J Gama-Rodrigues; N F Safatle; J C Reynolds
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 8.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

Authors:  P Correa
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

Review 9.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis.

Authors:  P Bechi; M Balzi; A Becciolini; A Maugeri; C C Raggi; A Amorosi; R Dei
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.